Psychiatry and Neurology, Neurology · Mc Lean, VA
NPI
1265424147
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
6845 Elm St, Suite 514
Mc Lean, VA, 22101
Phone (703) 260-6650
Groups this clinician bills Medicare through
Medicare paid, 2024
$199K
26,064 services
Medicare patients, 2024
507
Average age 78
Drug cost, 2024
$916K
3,858 prescriptions
Company payments, 2025
$1,956
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James L Bicksel was code 99215 (office e&m - established), 488 times for 263 patients. In total James L Bicksel billed 26,064 services in 23 codes, and Medicare paid $199K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 488 | 263 | $143.98 | $70K |
| 99214 Office E&M - Established | Office | 445 | 299 | $97.14 | $43K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 325 | 224 | $13.97 | $4,541 |
| 99213 Office E&M - Established | Office | 144 | 127 | $71.03 | $10K |
| 99483 Office/Outpatient Services | Office | 90 | 90 | $220.33 | $20K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 58 | 42 | $26.97 | $1,564 |
| 99205 Office E&M - New | Office | 38 | 38 | $184.38 | $7,006 |
| 11105 Skin Biopsy | Office | 38 | 19 | $51.17 | $1,944 |
| 96413 Chemotherapy Administration | Office | 34 | 11 | $119.67 | $4,069 |
| 99204 Office E&M - New | Office | 27 | 27 | $121.25 | $3,274 |
| 11104 Skin Biopsy | Office | 19 | 19 | $109.47 | $2,080 |
By year: 2022 $222K for 2,030 services; 2023 $214K for 1,790 services; 2024 $199K for 26,064 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 26 | 26 | $2.98 | $77.46 |
Medicare prescription drug claims, 2024
In 2024, the drug James L Bicksel prescribed most often to Medicare patients was Galantamine Er (Galantamine Hbr), with 359 prescriptions and refills. In total James L Bicksel wrote 3,858 Medicare prescriptions that cost $916K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Galantamine Er Galantamine Hbr | 359 | 836 | 96 | $40K |
| Sertraline Hcl Generic | 302 | 821 | 75 | $3,576 |
| Trazodone Hcl Generic | 252 | 542 | 88 | $3,390 |
| Donepezil Hcl Generic | 251 | 689 | 77 | $4,357 |
| Escitalopram Oxalate Generic | 222 | 539 | 66 | $3,414 |
| Memantine Hcl Er Memantine Hcl | 203 | 454 | 50 | $29K |
| Citalopram Hbr Citalopram Hydrobromide | 163 | 397 | 37 | $2,055 |
| Memantine Hcl Generic | 163 | 436 | 48 | $5,822 |
| Bupropion Xl Bupropion Hcl | 152 | 398 | 39 | $5,705 |
| Gabapentin Generic | 141 | 343 | 38 | $3,467 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 113 | 224 | 42 | $3,355 |
| Rivastigmine Generic | 112 | 266 | 32 | $36K |
| Mirtazapine Generic | 102 | 240 | 32 | $3,018 |
| Duloxetine Hcl Generic | 92 | 245 | 33 | $3,791 |
| Galantamine Hbr Generic | 58 | 128 | 18 | $6,492 |
Brand drugs: - claims; generic drugs: 3,645 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James L Bicksel $1,956 ($1,956 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $617.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $617 |
| Ge Healthcare GEHC | 11 | $315 |
| Abbott Laboratories ABT | 5 | $100 |
| Eisai Inc. 4523.T | 5 | $99.68 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $98.25 |
| Biogen, Inc. BIIB | 5 | $94.9 |
| ACADIA Pharmaceuticals Inc ACAD | 3 | $78.91 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $76.52 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $71.68 |
| Axsome Therapeutics, Inc. AXSM | 3 | $70.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.